Fmoc-Gly-Gly-Ser(Psi(Me,Me)Pro)-OH contains a pseudoproline dipeptide motif that disrupts aggregation during solid-phase synthesis. Gly-Gly provides a flexible spacer, while the Ser(Psi(Me,Me)Pro) unit transiently introduces a cyclic constraint. Researchers exploit this building block to improve difficult peptide assemblies and folding yields. Applications include SPPS optimization, aggregation-prone sequence construction, and conformational-control studies.
Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH, also known as a pseudoproline-containing tripeptide, is a specialized building block widely utilized in peptide synthesis research. Designed to enhance the efficiency and reliability of solid-phase peptide synthesis (SPPS), this compound features a unique pseudoproline motif at the serine residue, where the Psi(Me, Me)Pro modification introduces conformational constraints. The presence of the Fmoc (9-fluorenylmethyloxycarbonyl) protecting group allows for selective and sequential deprotection strategies, making it compatible with standard Fmoc-based SPPS protocols. The incorporation of the Gly-Gly sequence provides flexibility, while the pseudoproline modification serves to disrupt secondary structure formation during chain elongation. As a result, Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH is highly valued by researchers aiming to synthesize challenging peptide sequences with improved solubility and reduced aggregation tendencies.
Peptide Synthesis Optimization: Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH plays a pivotal role in optimizing the synthesis of long and aggregation-prone peptides. By integrating the pseudoproline dipeptide into growing peptide chains, researchers can effectively suppress premature folding and aggregation that often hinder chain extension. This disruption of secondary structure formation facilitates the assembly of difficult sequences, particularly those rich in hydrophobic or β-sheet-prone regions. The result is a higher overall yield and purity of the target peptide, enabling the synthesis of sequences that would otherwise be inaccessible or require extensive troubleshooting.
Enhanced Solubility in Peptide Chains: The pseudoproline motif within this tripeptide derivative enhances the solubility of peptide intermediates during SPPS. By introducing a conformationally constrained residue, it interrupts hydrogen bonding patterns that typically drive peptide aggregation. This property is especially beneficial when synthesizing peptides that are prone to forming insoluble intermediates, as it promotes better resin swelling and reagent accessibility. Consequently, the use of this building block can streamline purification steps and minimize losses due to precipitation or incomplete reactions.
Prevention of On-Resin Aggregation: In solid-phase peptide synthesis, on-resin aggregation is a common challenge that can compromise both the efficiency and fidelity of peptide assembly. The presence of the Ser(Psi(Me, Me)Pro) moiety in this compound acts as a temporary structural disruptor, preventing the formation of stable secondary structures while the peptide remains attached to the resin. This effect is reversible, as the pseudoproline can be removed under standard deprotection conditions, restoring the native serine residue and yielding the desired primary sequence without residual modification.
Facilitation of Difficult Sequence Synthesis: Many bioactive peptides and proteins contain regions that are notoriously difficult to synthesize due to their propensity for aggregation or incomplete coupling. The strategic use of Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH enables researchers to bypass these obstacles by temporarily masking problematic segments with the pseudoproline motif. This approach has been successfully applied in the synthesis of peptides with multiple consecutive glycine or serine residues, as well as sequences containing motifs that promote β-turn or β-sheet formation. By simplifying the synthesis of such challenging regions, this compound expands the range of accessible peptide targets for research and development.
Structure-Activity Relationship Studies: The ability to incorporate and subsequently remove the pseudoproline modification makes this compound invaluable for structure-activity relationship (SAR) investigations. Researchers can systematically introduce the pseudoproline motif at various positions within a peptide sequence to examine its effects on folding, stability, and biological activity. After synthesis and deprotection, the resulting peptides can be compared to their unmodified counterparts to assess how transient structural constraints influence function. This strategy provides insights into the design of more stable or bioactive peptide analogs, supporting the development of novel research tools and therapeutic candidates.
Fmoc-Gly-Gly-Ser(Psi(Me, Me)Pro)-OH stands as a versatile and essential tool for peptide chemists seeking to overcome the inherent challenges of solid-phase peptide synthesis. Its unique combination of structural features and functional benefits enables the efficient assembly of complex and aggregation-prone peptides, enhances solubility and handling during synthesis, and supports advanced studies in peptide structure and function. By facilitating the synthesis of difficult sequences and enabling detailed SAR analyses, this pseudoproline-containing building block continues to drive innovation in peptide research, expanding the frontiers of biomolecular science and synthetic methodology.
1. Emerging applications of nanotechnology for diagnosis and therapy of disease: a review
2. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
3. High fat diet and GLP-1 drugs induce pancreatic injury in mice
5. Cationic cell-penetrating peptides are potent furin inhibitors
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More